Pemetrexed-carboplatin with intercalated icotinib in the treatment of patient with advanced EGFR wild-type lung adenocarcinoma

MLA

Shidai Jin, et al. “Pemetrexed-Carboplatin with Intercalated Icotinib in the Treatment of Patient with Advanced EGFR Wild-Type Lung Adenocarcinoma.” Medicine, vol. 96, Aug. 2017, p. e7732. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....11be362e673ea9f82ee0654fd2f45744&authtype=sso&custid=ns315887.

APA

Shidai Jin, Huang Min, Wei Wen, Zhihong Zhang, Renhua Guo, Hao Wu, Tongpeng Xu, & Yongqian Shu. (2017). Pemetrexed-carboplatin with intercalated icotinib in the treatment of patient with advanced EGFR wild-type lung adenocarcinoma. Medicine, 96, e7732.

Chicago

Shidai Jin, Huang Min, Wei Wen, Zhihong Zhang, Renhua Guo, Hao Wu, Tongpeng Xu, and Yongqian Shu. 2017. “Pemetrexed-Carboplatin with Intercalated Icotinib in the Treatment of Patient with Advanced EGFR Wild-Type Lung Adenocarcinoma.” Medicine 96 (August): e7732. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....11be362e673ea9f82ee0654fd2f45744&authtype=sso&custid=ns315887.